Logo image
4-Phenoxypiperidine pyridazin-3-one histamine H-3 receptor inverse agonists demonstrating potent and robust wake promoting activity
Journal article   Open access   Peer reviewed

4-Phenoxypiperidine pyridazin-3-one histamine H-3 receptor inverse agonists demonstrating potent and robust wake promoting activity

Robert L. Hudkins, Allison L. Zulli, Reddeppa Reddy Dandu, Ming Tao, Kurt A. Josef, Lisa D. Aimone, R. Curtis Haltiwanger, Zeqi Huang, Jacquelyn A. Lyons, Joanne R. Mathiasen, …
Bioorganic & medicinal chemistry letters, v 22(4), pp 1504-1509
15 Feb 2012
PMID: 22290075
url
https://doi.org/10.7270/q2w37wsfView
Open

Abstract

Chemistry Chemistry, Medicinal Chemistry, Organic Life Sciences & Biomedicine Pharmacology & Pharmacy Physical Sciences Science & Technology
Structure-activity relationships for a series of phenoxypiperidine pyridazin-3-one H3R antagonists/inverse agonists are disclosed. The search for compounds with improved hERG and DAT selectivity without the formation of in vivo active metabolites identified 6-[4-(1-cyclobutyl-piperidin-4-yloxy)phenyl]- 4,4-dimethyl-4,5-dihydro-2H-pyridazin-3-one 17b. Compound 17b met discovery flow criteria, demonstrated potent H3R functional antagonism in vivo in the rat dipsogenia model and potent wake activity in the rat EEG/EMG model at doses as low as 0.1 mg/kg ip. (C) 2012 Elsevier Ltd. All rights reserved.

Metrics

8 Record Views
12 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Chemistry, Medicinal
Chemistry, Organic
Logo image